scispace - formally typeset
P

Peter Siesjö

Researcher at Lund University

Publications -  93
Citations -  3834

Peter Siesjö is an academic researcher from Lund University. The author has contributed to research in topics: Glioma & Immunotherapy. The author has an hindex of 27, co-authored 84 publications receiving 3415 citations. Previous affiliations of Peter Siesjö include University of Cape Town & University of Jordan.

Papers
More filters
Journal ArticleDOI

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

Paul A. Northcott, +79 more
- 24 Jul 2014 - 
TL;DR: GFI1 and GFI1B are identified as prominent medulloblastoma oncogenes and ‘enhancer hijacking’ is implicate as an efficient mechanism driving oncogene activation in a childhood cancer.
Journal ArticleDOI

Mechanisms of secondary brain injury

TL;DR: It has now been found that the secondary deterioration of the bioenergetic state of core and penumbral tissues are mirrored by corresponding changes in the respiratory functions of isolated mitochondria, suggesting that, also in this type of ischaemia, the mitochondria suffer secondary damage.
Journal ArticleDOI

Glutamate, calcium, and free radicals as mediators of ischemic brain damage

TL;DR: In vitro and in vivo experiments suggest that the main route of entry is through channels gated by glutamate receptors, leading to the excitotoxic hypothesis of cell death and in vitro experiments further support the role of calcium as a mediator of cellDeath.
Journal ArticleDOI

Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis

TL;DR: The objective of this article is to amalgamate previous results into a speculative synthesis that sheds light on the causes of secondary brain damage following either global/forebrain or focal ischemia, based on the well-founded assumption that the pathophysiology of the brain damage incurred by global or forebrain ischemIA is different from that of focal isChemia.
Journal ArticleDOI

Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target

TL;DR: It is shown that a large proportion of primary medulloblastomas and medullOBlastoma cell lines are infected with HCMV and that COX-2 expression, along with PGE2 levels, in tumors is directly modulated by the virus.